The firm was also recognized for its role in the “Healthcare Deal of the Year.”
Willkie was honored at The Deal Awards Europe, which recognizes “the leaders of the deal economy” – the advisors and service providers involved in the most significant cross-border deals in Europe and around the globe.
Willkie was named “Financial Services Law Firm of the Year,” a top honor in recognition of its notable cross-border M&A and private equity transactional work on behalf of clients in the financial services sector. The firm was also honored for “Healthcare, Pharma & Biotech Deal of the Year,” for its representation of Centerview Partners in GlaxoSmithKline’s acquisition of cancer drug specialist Tesaro.
Willkie was also shortlisted for its role in:
Fidelity National’s acquisition of London payment tech company Worldpay (Financial Services Deal of the Year)
Westlake Chemical’s acquisition of PVC compounding company Nakan from OpenGate Capital (Middle-Market Deal of the Year)
In its second year, The Deal Awards Europe focuses on the most significant European deals over the past year across various industry sectors that involve at least one UK or European company and include advisers from around the world. The Deal is a news and intelligence platform for mergers, acquisitions and all other changes in corporate control, covering US and international deals and dealmakers.
The event took place on October 30, 2019 in London.